CAS 2010-15-3|PTH-glycine
Introduction：Basic information about CAS 2010-15-3|PTH-glycine, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | PTH-glycine | ||
|---|---|---|---|
| CAS Number | 2010-15-3 | Molecular Weight | 192.23800 |
| Density | 1.39g/cm3 | Boiling Point | 292.1ºC at 760mmHg |
| Molecular Formula | C9H8N2OS | Melting Point | / |
| MSDS | ChineseUSA | Flash Point | 130.5ºC |
| Symbol | GHS06 | Signal Word | Danger |
Names
| Name | pth-glycine |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.39g/cm3 |
|---|---|
| Boiling Point | 292.1ºC at 760mmHg |
| Molecular Formula | C9H8N2OS |
| Molecular Weight | 192.23800 |
| Flash Point | 130.5ºC |
| Exact Mass | 192.03600 |
| PSA | 64.43000 |
| LogP | 1.30150 |
| Index of Refraction | 1.684 |
| InChIKey | ZZRIQDWDJVLELF-UHFFFAOYSA-N |
| SMILES | O=C1CNC(=S)N1c1ccccc1 |
| Storage condition | −20°C |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 155 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- FRZKAP Farmatsevtichnii Zhurnal (Kiev). (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.3- 1930- Volume(issue)/page/year: 17(1),36,1962
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 75 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. Volume(issue)/page/year: AD691-490
Safety Information
| Symbol | GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301-H311-H331 |
| Precautionary Statements | P261-P280-P301 + P310-P311 |
| Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
| Hazard Codes | T: Toxic; |
| Risk Phrases | 23/24/25 |
| Safety Phrases | S36/37/39-S45 |
| RIDADR | UN 2811 6.1/PG 3 |
| WGK Germany | 3 |
| RTECS | MU4025000 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |
| HS Code | 2933990090 |
Customs
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Articles45
More Articles| Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis. J. Biol. Chem. 288(27) , 19359-69, (2013) Despite the fact that androgen deprivation therapy (ADT) can effectively reduce prostate cancer (PCa) size, its effect on PCa metastasis remains unclear. We examined the existing data on PCa patients ... | |
| Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100. Cancer Res. 73(9) , 2926, (2013) | |
| Combined blockade of testicular and locally made androgens in prostate cancer: a highly significant medical progress based upon intracrinology. J. Steroid Biochem. Mol. Biol. 145 , 144-56, (2015) Recently two drugs, namely the antiandrogen MDV-3100 and the inhibitor of 17α-hydroxylase abiraterone have been accepted by the FDA for the treatment of castration-resistant prostate cancer (CRPC) wit... |
Synonyms
| 3-phenyl-2-thio-hydantoi |
| 3-(phenyl)-2-thioxo-4-imidazolidinone |
| 3-PHENYL-2-THIOXO-4-IMIDAZOLIDINONE |
| 3-Phenyl-2-thiohydantoin |
| 3-phenyl-2-thioguidanthion |
| glycine,3-phenyl-2-thiohydantoin |
| EINECS 217-927-3 |
| PHENYLTHIOHYDANTOIN-DL-GLYCINE |
| (E)-2-cyano-3-(4-fluorophenyl)prop-2-enethioamide |
| PHENYLTHIOHYDANTOIN-GLYCINE |
| 1-phenyl-2-thiohydantoin |
| phenylthiohydantoin |
| 3-phenyl-2-thioxotetrahydro-4H-imidazol-4-one |
| PTH-DL-GLYCINE |
| 3-phenyl-2-thioxoimidazolidin-4-one |
| MFCD00027413 |
